Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-04-23

FDA Approved: AMLODIPINE BESYLATE — Supplemental Application (POLYGEN PHARMACEUTICALS INC.)

View source ↗

Summary

FDA approved a supplemental application for amlodipine besylate from PolyGen Pharmaceuticals, approving a generic version.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Amlodipine besylate (amlodipine besylate)

Snippet

SUPPL AP for AMLODIPINE BESYLATE (AMLODIPINE BESYLATE)